Stockreport

AnaptysBio Details Plan to Split Into RoyaltyCo and Biopharma at TD Cowen Healthcare Conference [Yahoo! Finance]

AnaptysBio, Inc.  (ANAB) 
Last anaptysbio, inc. earnings: 3/2 08:45 am Check Earnings Report
US:NASDAQ Investor Relations: ir.anaptysbio.com/investor-relations
PDF holding Jemperli and future imsidolimab royalties, and a development-focused biopharma company housing ANB033, ANB101, rosnilimab, cash and employees. Jemperli is the [Read more]